PetMed Express Analyst Ratings
PetMed Express Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/19/2023 | -1.57% | Morgan Stanley | $17 → $10 | Maintains | Underweight |
| 07/27/2023 | 67.32% | Morgan Stanley | $17 → $17 | Reiterates | Underweight → Underweight |
| 05/25/2023 | 96.85% | Lake Street | → $20 | Initiates Coverage On | → Buy |
| 03/23/2023 | 67.32% | Morgan Stanley | $18 → $17 | Maintains | Underweight |
| 11/08/2022 | 77.17% | Morgan Stanley | $19 → $18 | Maintains | Underweight |
| 07/26/2022 | 87.01% | Morgan Stanley | $20 → $19 | Maintains | Underweight |
| 05/10/2022 | 96.85% | Morgan Stanley | $21 → $20 | Maintains | Underweight |
| 01/25/2022 | 106.69% | Morgan Stanley | $25 → $21 | Maintains | Underweight |
| 01/20/2022 | 214.96% | Sidoti & Co. | → $32 | Upgrades | Neutral → Buy |
| 11/18/2021 | 146.06% | Morgan Stanley | → $25 | Initiates Coverage On | → Underweight |
| 10/01/2021 | 175.59% | Jefferies | → $28 | Initiates Coverage On | → Hold |
| 06/03/2021 | 283.86% | Sidoti & Co. | → $39 | Downgrades | Buy → Neutral |
| 03/05/2021 | — | Sidoti & Co. | Upgrades | Neutral → Buy | |
| 08/19/2020 | 303.54% | Sidoti & Co. | $37 → $41 | Upgrades | Neutral → Buy |
| 02/24/2020 | — | Sidoti & Co. | Downgrades | Buy → Neutral | |
| 10/17/2019 | 96.85% | Craig-Hallum | $15 → $20 | Maintains | Hold |
| 08/16/2019 | — | Craig-Hallum | Downgrades | Buy → Hold |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2023 年 10 月 19 日 | -1.57% | 摩根士丹利 | 17 美元 → 10 美元 | 维持 | 体重不足 |
| 07/27/2023 | 67.32% | 摩根士丹利 | 17 美元 → 17 美元 | 重申 | 体重过轻 → 体重不足 |
| 05/25/2023 | 96.85% | 湖街 | → 20 美元 | 启动覆盖范围开启 | → 购买 |
| 03/23/2023 | 67.32% | 摩根士丹利 | 18 美元 → 17 美元 | 维持 | 体重不足 |
| 2022 年 8 月 11 日 | 77.17% | 摩根士丹利 | 19 美元 → 18 美元 | 维持 | 体重不足 |
| 07/26/2022 | 87.01% | 摩根士丹利 | 20 美元 → 19 美元 | 维持 | 体重不足 |
| 05/10/2022 | 96.85% | 摩根士丹利 | 21 美元 → 20 美元 | 维持 | 体重不足 |
| 01/25/2022 | 106.69% | 摩根士丹利 | 25 美元 → 21 美元 | 维持 | 体重不足 |
| 01/20/2022 | 214.96% | Sidoti & Co. | → 32 美元 | 升级 | 中性 → 买入 |
| 11/18/2021 | 146.06% | 摩根士丹利 | → 25 美元 | 启动覆盖范围开启 | → 体重不足 |
| 10/01/2021 | 175.59% | 杰富瑞集团 | → 28 美元 | 启动覆盖范围开启 | → 按住 |
| 06/03/2021 | 283.86% | Sidoti & Co. | → 39 美元 | 降级 | 买入 → 中性 |
| 03/05/2021 | — | Sidoti & Co. | 升级 | 中性 → 买入 | |
| 2020 年 8 月 19 日 | 303.54% | Sidoti & Co. | 37 美元 → 41 美元 | 升级 | 中性 → 买入 |
| 2020 年 2 月 24 日 | — | Sidoti & Co. | 降级 | 买入 → 中性 | |
| 10/17/2019 | 96.85% | Craig-Hallum | 15 美元 → 20 美元 | 维持 | 按住 |
| 2019 年 8 月 16 日 | — | Craig-Hallum | 降级 | 买入 → 持有 |
What is the target price for PetMed Express (PETS)?
PetMed Express (PETS) 的目标价格是多少？
The latest price target for PetMed Express (NASDAQ: PETS) was reported by Morgan Stanley on October 19, 2023. The analyst firm set a price target for $10.00 expecting PETS to fall to within 12 months (a possible -1.57% downside). 5 analyst firms have reported ratings in the last year.
摩根士丹利于2023年10月19日公布了PetMed Express（纳斯达克股票代码：PETS）的最新目标股价。该分析公司将目标股价设定为10.00美元，预计PETS将在12个月内跌至-1.57％（下跌幅度可能为-1.57％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for PetMed Express (PETS)?
分析师对PetMed Express（PETS）的最新评级是多少？
The latest analyst rating for PetMed Express (NASDAQ: PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.
摩根士丹利提供了PetMed Express（纳斯达克股票代码：PETS）的最新分析师评级，PetMed Express维持其减持评级。
When is the next analyst rating going to be posted or updated for PetMed Express (PETS)?
PetMed Express（PETS）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on October 19, 2023 so you should expect the next rating to be made available sometime around October 19, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与PetMed Express的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。PetMed Express的最后一次评级是在2023年10月19日提交的，因此您应该预计下一个评级将在2024年10月19日左右公布。
Is the Analyst Rating PetMed Express (PETS) correct?
分析师对 PetMed Express (PETS) 的评级正确吗？
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $17.00 to $10.00. The current price PetMed Express (PETS) is trading at is $10.16, which is out of the analyst's predicted range.
尽管评级是主观的，并将发生变化，但最新的PetMed Express（PETS）评级维持不变，目标股价为17.00美元至10.00美元。PetMed Express（PETS）目前的交易价格为10.16美元，超出了分析师的预测区间。